• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加利福尼亚州阿片类药物使用障碍的中心辐射模型的实施:基本原理、设计和预期影响。

Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.

机构信息

University of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America.

Stanford University School of Medicine, 1520 Page Mill Road, MC 5265, Palo Alto, CA 94304, United States of America.

出版信息

J Subst Abuse Treat. 2020 Jan;108:20-25. doi: 10.1016/j.jsat.2019.07.013. Epub 2019 Jul 27.

DOI:10.1016/j.jsat.2019.07.013
PMID:31399272
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6893120/
Abstract

As part of the State Targeted Response to the opioid epidemic, California has adopted the Hub and Spoke model to expand access to medications for opioid use disorder, particularly buprenorphine, throughout the state. By aligning opioid treatment programs as hubs with primary care, office-based practitioners, and other health care settings as spokes, a broader treatment model can reach more people with opioid use disorder, improve access to medications for opioid use disorders, and decrease overdose deaths. Expanding access requires expanding knowledge and intensive implementation support of new practices. This paper describes the rationale, specific activities and anticipated impact of the implementation plan in California's Hub and Spoke system. Training and technical assistance are designed to: increase the number and capacity of waivered prescribers; enhance skills of prescribers and multidisciplinary teams; and create systems change. Activities include buprenorphine waiver trainings and provider support, a practice facilitator program, Project ECHO sessions, webinars, clinical skills trainings, and regional learning collaboratives. This overview highlights the steps California is taking to build treatment capacity to address the opioid epidemic.

摘要

作为国家应对阿片类药物流行的一部分,加利福尼亚州已采用中心辐射模型,以扩大全州范围内阿片类药物使用障碍(尤其是丁丙诺啡)的药物获取渠道。通过将阿片类药物治疗项目作为中心,将初级保健、以办公室为基础的从业者和其他医疗保健环境作为辐射点,更广泛的治疗模式可以覆盖更多的阿片类药物使用障碍患者,改善阿片类药物使用障碍的药物获取渠道,并减少过量死亡人数。扩大获取渠道需要扩大新知识,并为新实践提供深入的实施支持。本文介绍了加利福尼亚州中心辐射系统中实施计划的基本原理、具体活动和预期影响。培训和技术援助旨在:增加有豁免权的处方医生的数量和能力;提高处方医生和多学科团队的技能;并进行系统变革。活动包括丁丙诺啡豁免培训和提供者支持、实践促进者计划、ECHO 项目会议、网络研讨会、临床技能培训和区域学习合作。本文概述了加利福尼亚州为建立治疗能力以应对阿片类药物流行而采取的措施。

相似文献

1
Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.加利福尼亚州阿片类药物使用障碍的中心辐射模型的实施:基本原理、设计和预期影响。
J Subst Abuse Treat. 2020 Jan;108:20-25. doi: 10.1016/j.jsat.2019.07.013. Epub 2019 Jul 27.
2
Preliminary results of the evaluation of the California Hub and Spoke Program.加利福尼亚轴心辐射计划评估的初步结果。
J Subst Abuse Treat. 2020 Jan;108:26-32. doi: 10.1016/j.jsat.2019.07.014. Epub 2019 Aug 1.
3
The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.华盛顿州中心辐射模型,以增加获得阿片类药物使用障碍药物治疗的机会。
J Subst Abuse Treat. 2020 Jan;108:33-39. doi: 10.1016/j.jsat.2019.07.007. Epub 2019 Jul 19.
4
System-level factors shaping the implementation of "hub and spoke" systems to expand MOUD in rural areas.影响“中心辐射”模式在农村地区扩大美沙酮维持治疗项目实施的系统因素。
Subst Abus. 2021;42(4):716-725. doi: 10.1080/08897077.2020.1846149. Epub 2020 Dec 7.
5
Implementation and evaluation of Missouri's Medication First treatment approach for opioid use disorder in publicly-funded substance use treatment programs.在公立药物滥用治疗项目中实施和评估密苏里州的药物优先治疗阿片类药物使用障碍的方法。
J Subst Abuse Treat. 2020 Jan;108:55-64. doi: 10.1016/j.jsat.2019.06.015. Epub 2019 Jun 26.
6
Access to treatment for opioid use disorders: Medical student preparation.阿片类物质使用障碍的治疗途径:医学生的准备工作。
Am J Addict. 2017 Jun;26(4):316-318. doi: 10.1111/ajad.12550. Epub 2017 Apr 10.
7
The case for a medication first approach to the treatment of opioid use disorder.采用药物优先治疗阿片类药物使用障碍。
Am J Drug Alcohol Abuse. 2019;45(4):333-340. doi: 10.1080/00952990.2019.1605372. Epub 2019 May 14.
8
Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system.患者对佛蒙特州中心辐射式系统中使用药物治疗阿片类药物使用障碍(MOUD)的治疗感受。
Prev Med. 2019 Nov;128:105785. doi: 10.1016/j.ypmed.2019.105785. Epub 2019 Jul 27.
9
Association of Buprenorphine-Waivered Physician Supply With Buprenorphine Treatment Use and Prescription Opioid Use in Medicaid Enrollees.美沙酮处方医师人数与医疗补助计划参保者美沙酮治疗使用和处方类阿片药物使用的关联。
JAMA Netw Open. 2018 Sep 7;1(5):e182943. doi: 10.1001/jamanetworkopen.2018.2943.
10
Prescribing patterns of buprenorphine waivered physicians.有资格开丁丙诺啡的医师的处方模式。
Drug Alcohol Depend. 2017 Dec 1;181:213-218. doi: 10.1016/j.drugalcdep.2017.10.002. Epub 2017 Oct 18.

引用本文的文献

1
The linkage between opioid treatment programs and recovery community centers: results of a survey of OTP directors.阿片类药物治疗项目与康复社区中心之间的联系:对阿片类药物治疗项目主任的调查结果
Front Public Health. 2025 Aug 7;13:1532374. doi: 10.3389/fpubh.2025.1532374. eCollection 2025.
2
"You don't have the right resources to let it hurt": How structural vulnerabilities shape opioid withdrawal experiences among a community sample of people who inject drugs in Los Angeles, California.“你没有合适的资源任由其造成伤害”:结构性脆弱性如何塑造加利福尼亚州洛杉矶市一个注射吸毒者社区样本中的阿片类药物戒断体验。
Harm Reduct J. 2025 May 19;22(1):82. doi: 10.1186/s12954-025-01223-x.
3
Impact of an opioid use disorder medication implementation intervention on hospitalization and emergency department utilization in the Veterans Health Administration.阿片类药物使用障碍药物实施干预对退伍军人健康管理局住院和急诊科利用情况的影响。
BMC Psychiatry. 2025 Mar 26;25(1):288. doi: 10.1186/s12888-025-06722-6.
4
Patient centered medication treatment for opioid use disorder in rural Vermont: a qualitative study.佛蒙特州农村地区以患者为中心的阿片类药物使用障碍药物治疗:一项定性研究
Addict Sci Clin Pract. 2025 Jan 14;20(1):3. doi: 10.1186/s13722-024-00529-8.
5
Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise.杜氏肌营养不良症的基因治疗:评估意大利专业中心的准备情况。
Acta Myol. 2024 Sep;43(3):95-101. doi: 10.36185/2532-1900-487.
6
Relationship of hub and treatment characteristics with client outcomes in the initial Washington State hub and spoke cohort.华盛顿州首个枢纽与辐条式队列研究中枢纽及治疗特征与客户结局的关系。
J Subst Use Addict Treat. 2025 Jan;168:209544. doi: 10.1016/j.josat.2024.209544. Epub 2024 Oct 20.
7
Linkage facilitation for opioid use disorder in criminal legal system contexts: a primer for researchers, clinicians, and legal practitioners.刑事法律系统背景下阿片类物质使用障碍的联动促进:研究人员、临床医生和法律从业者入门指南
Health Justice. 2024 Aug 29;12(1):36. doi: 10.1186/s40352-024-00291-8.
8
US payment policy for medications to treat opioid use disorder: landscape and opportunities.美国治疗阿片类药物使用障碍药物的支付政策:现状与机遇
Health Aff Sch. 2024 Feb 27;2(3):qxae024. doi: 10.1093/haschl/qxae024. eCollection 2024 Mar.
9
Developing an educational "hub": impact of a distance-learning curriculum in a multinational cohort.建立教育“枢纽”:跨国队列中远程学习课程的影响。
BMC Med Educ. 2024 Apr 12;24(1):406. doi: 10.1186/s12909-024-05193-9.
10
Statewide efforts to address the opioid epidemic: Results from a national survey of single state agencies.全州范围内解决阿片类药物泛滥问题的努力:全国单一州机构调查的结果。
J Subst Use Addict Treat. 2024 May;160:209309. doi: 10.1016/j.josat.2024.209309. Epub 2024 Feb 8.

本文引用的文献

1
Assessment of medication for opioid use disorder as delivered within the Vermont hub and spoke system.评估佛蒙特州中心辐射系统中提供的阿片类药物使用障碍治疗药物。
J Subst Abuse Treat. 2019 Feb;97:84-90. doi: 10.1016/j.jsat.2018.11.003. Epub 2018 Nov 19.
2
Drug Overdose Deaths in the United States, 1999-2017.1999 - 2017年美国药物过量致死情况
NCHS Data Brief. 2018 Nov(329):1-8.
3
Substance use, recovery, and linguistics: The impact of word choice on explicit and implicit bias.物质使用、恢复和语言学:词汇选择对显性和隐性偏见的影响。
Drug Alcohol Depend. 2018 Aug 1;189:131-138. doi: 10.1016/j.drugalcdep.2018.05.005. Epub 2018 Jun 13.
4
Using ECHO Clinics to Promote Capacity Building in Clinical Supervision.利用 ECHO 诊所促进临床督导能力建设。
Am J Prev Med. 2018 Jun;54(6 Suppl 3):S275-S280. doi: 10.1016/j.amepre.2018.01.015.
5
Why aren't physicians prescribing more buprenorphine?为什么医生没有开出更多的丁丙诺啡?
J Subst Abuse Treat. 2017 Jul;78:1-7. doi: 10.1016/j.jsat.2017.04.005. Epub 2017 Apr 12.
6
Using implementation facilitation to foster clinical practice quality and adherence to evidence in challenged settings: a qualitative study.在具有挑战性的环境中利用实施促进措施提高临床实践质量并促进循证实践:一项定性研究
BMC Health Serv Res. 2017 Apr 20;17(1):294. doi: 10.1186/s12913-017-2217-0.
7
Vermont Hub-and-Spoke Model of Care for Opioid Use Disorder: Development, Implementation, and Impact.佛蒙特州阿片类药物使用障碍的中心辐射式护理模式:发展、实施与影响
J Addict Med. 2017 Jul/Aug;11(4):286-292. doi: 10.1097/ADM.0000000000000310.
8
Primary Care-Based Models for the Treatment of Opioid Use Disorder: A Scoping Review.基于初级保健的阿片类物质使用障碍治疗模式:一项范围综述
Ann Intern Med. 2017 Feb 21;166(4):268-278. doi: 10.7326/M16-2149. Epub 2016 Dec 6.
9
The Impact of Project ECHO on Participant and Patient Outcomes: A Systematic Review.“拓展社区医疗成果”(ECHO)项目对参与者和患者治疗结果的影响:一项系统综述
Acad Med. 2016 Oct;91(10):1439-1461. doi: 10.1097/ACM.0000000000001328.
10
Using a Theory-Guided Learning Collaborative Model to Improve Implementation of EBPs in a State Children's Mental Health System: A Pilot Study.运用理论指导的学习协作模型改善州立儿童心理健康系统中循证实践的实施:一项试点研究。
Adm Policy Ment Health. 2016 Nov;43(6):978-990. doi: 10.1007/s10488-016-0735-4.